S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Israel hails 'success' in blocking Iran's unprecedented attack. Biden now seeks diplomatic response
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Germany's Scholz arrives in China on a visit marked by trade tensions and Ukraine conflict
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
Olympic track uniforms spark online debate about who designed them and why they're so skimpy
The craze for Masters gnomes is growing. Little golf-centric statue is now a coveted collector item
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Israel hails 'success' in blocking Iran's unprecedented attack. Biden now seeks diplomatic response
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Germany's Scholz arrives in China on a visit marked by trade tensions and Ukraine conflict
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
Olympic track uniforms spark online debate about who designed them and why they're so skimpy
The craze for Masters gnomes is growing. Little golf-centric statue is now a coveted collector item
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Israel hails 'success' in blocking Iran's unprecedented attack. Biden now seeks diplomatic response
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Germany's Scholz arrives in China on a visit marked by trade tensions and Ukraine conflict
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
Olympic track uniforms spark online debate about who designed them and why they're so skimpy
The craze for Masters gnomes is growing. Little golf-centric statue is now a coveted collector item
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Israel hails 'success' in blocking Iran's unprecedented attack. Biden now seeks diplomatic response
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Germany's Scholz arrives in China on a visit marked by trade tensions and Ukraine conflict
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
Olympic track uniforms spark online debate about who designed them and why they're so skimpy
The craze for Masters gnomes is growing. Little golf-centric statue is now a coveted collector item

G1 Therapeutics (GTHX) News Today

$4.55
-0.13 (-2.78%)
(As of 04/12/2024 ET)
SourceHeadline
MarketBeat logoG1 Therapeutics (NASDAQ:GTHX) Given Buy Rating at Needham & Company LLC
americanbankingnews.com - April 14 at 5:14 AM
markets.businessinsider.com logoBuy Rating for G1 Therapeutics: Market Position and Growth Potential Solidify Investment Appeal
markets.businessinsider.com - April 12 at 2:35 PM
markets.businessinsider.com logoBreaking Down G1 Therapeutics: 5 Analysts Share Their Views
markets.businessinsider.com - April 12 at 2:35 PM
marketbeat.com logoG1 Therapeutics (NASDAQ:GTHX) Given "Buy" Rating at Needham & Company LLC
marketbeat.com - April 12 at 8:24 AM
MarketBeat logoHead-To-Head Survey: G1 Therapeutics (NASDAQ:GTHX) vs. Galmed Pharmaceuticals (NASDAQ:GLMD)
americanbankingnews.com - April 7 at 1:16 AM
globenewswire.com logoG1 Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference
globenewswire.com - April 4 at 10:30 AM
globenewswire.com logoG1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com - April 1 at 4:20 PM
marketwatch.com logoG1 Therapeutics Cuts Executive Salaries by 10% Amid Cost-Cutting Measures
marketwatch.com - March 22 at 11:29 PM
seekingalpha.com logoWhy G1 Therapeutics Is A Speculative 'Buy' In The Oncology Biotech Landscape
seekingalpha.com - March 22 at 6:29 PM
insidertrades.com logoG1 Therapeutics, Inc. (NASDAQ:GTHX) CFO Sells $19,771.94 in Stock
insidertrades.com - March 21 at 10:33 AM
marketbeat.com logoJohn W. V. Umstead Sells 6,547 Shares of G1 Therapeutics, Inc. (NASDAQ:GTHX) Stock
marketbeat.com - March 20 at 8:13 PM
marketbeat.com logoShort Interest in G1 Therapeutics, Inc. (NASDAQ:GTHX) Drops By 12.6%
marketbeat.com - March 16 at 10:40 PM
finance.yahoo.com logoGTHX Apr 2024 3.000 call
finance.yahoo.com - March 16 at 12:54 AM
finance.yahoo.com logoGTHX Apr 2024 3.500 put
finance.yahoo.com - March 16 at 12:54 AM
finance.yahoo.com logoGTHX Mar 2024 3.000 put
finance.yahoo.com - March 6 at 11:21 PM
globenewswire.com logoG1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com - March 1 at 4:20 PM
seekingalpha.com logoG1 Therapeutics, Inc. (GTHX) Q4 2023 Earnings Call Transcript
seekingalpha.com - March 1 at 10:53 AM
marketbeat.com logoAnalysts Offer Predictions for G1 Therapeutics, Inc.'s Q3 2024 Earnings (NASDAQ:GTHX)
marketbeat.com - March 1 at 8:02 AM
markets.businessinsider.com logoBuy Rating Justified by G1 Therapeutics’ Strong Q4 Earnings and Cosela’s Market Traction
markets.businessinsider.com - February 29 at 1:24 PM
finance.yahoo.com logoG1 Therapeutics, Inc. (NASDAQ:GTHX) Q4 2023 Earnings Call Transcript
finance.yahoo.com - February 29 at 1:24 PM
finance.yahoo.com logoQ4 2023 G1 Therapeutics Inc Earnings Call
finance.yahoo.com - February 29 at 1:56 AM
investing.com logoG1 Therapeutics Inc (GTHX)
investing.com - February 28 at 8:55 PM
finance.yahoo.com logoGTHX Jul 2024 2.500 put
finance.yahoo.com - February 28 at 3:55 PM
msn.com logoG1 Therapeutics GAAP EPS of -$0.21 beats by $0.07, revenue of $14.9M beats by $1.87M
msn.com - February 28 at 3:55 PM
markets.businessinsider.com logoForecasting The Future: 5 Analyst Projections For G1 Therapeutics
markets.businessinsider.com - February 28 at 3:55 PM
finance.yahoo.com logoG1 Therapeutics Inc (GTHX) Reports Strong Revenue Growth in 2023
finance.yahoo.com - February 28 at 10:55 AM
globenewswire.com logoG1 Therapeutics Provides Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
globenewswire.com - February 28 at 6:30 AM
globenewswire.com logoG1 Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference
globenewswire.com - February 27 at 8:30 AM
finance.yahoo.com logoG1 Therapeutics, Inc.'s (NASDAQ:GTHX) 47% loss last week hit both individual investors who own 60% as well as institutions
finance.yahoo.com - February 17 at 10:29 AM
finance.yahoo.com logoG1 Therapeutics to Release Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on February 28, 2024
finance.yahoo.com - February 15 at 3:20 PM
marketbeat.com logoG1 Therapeutics, Inc. (NASDAQ:GTHX) to Post FY2025 Earnings of ($0.52) Per Share, Wedbush Forecasts
marketbeat.com - February 15 at 8:44 AM
globenewswire.com logoG1 Therapeutics to Release Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on February 28, 2024
globenewswire.com - February 15 at 8:30 AM
finance.yahoo.com logoGTHX Feb 2024 7.500 put
finance.yahoo.com - February 14 at 10:55 PM
msn.com logoG1 Therapeutics stock sinks 53% in wake of study update
msn.com - February 13 at 9:16 PM
marketwatch.com logoG1 Therapeutics Shares Down 54% After Cancer Study Update, Wedbush Price Target Cut
marketwatch.com - February 13 at 4:16 PM
marketbeat.com logoG1 Therapeutics Sees Unusually High Options Volume (NASDAQ:GTHX)
marketbeat.com - February 13 at 12:54 PM
msn.com logoG1 Therapeutics, CareCloud among healthcare movers
msn.com - February 13 at 10:41 AM
investorplace.com logoWhy Is G1 Therapeutics (GTHX) Stock Down 45% Today?
investorplace.com - February 13 at 9:12 AM
marketbeat.com logoWedbush Cuts G1 Therapeutics (NASDAQ:GTHX) Price Target to $4.00
marketbeat.com - February 13 at 8:41 AM
marketwatch.com logoShares G1 Therapeutics Tumble 46% Following Update to Phase 3 Breast Cancer Study
marketwatch.com - February 12 at 8:01 PM
finance.yahoo.com logoG1 Therapeutics to Continue Pivotal Phase 3 Trial of Trilaciclib in Metastatic Triple Negative Breast Cancer Following Interim Analysis by Independent Data Monitoring Committee
finance.yahoo.com - February 12 at 8:01 PM
benzinga.com logoG1 Therapeutics Options Trading: A Deep Dive into Market Sentiment
benzinga.com - February 12 at 3:00 PM
ca.finance.yahoo.com logoG1 Therapeutics, Inc. (GTHX)
ca.finance.yahoo.com - January 31 at 9:57 AM
marketbeat.com logoG1 Therapeutics, Inc. (NASDAQ:GTHX) Short Interest Update
marketbeat.com - January 29 at 2:38 AM
marketbeat.com logoNeedham & Company LLC Reaffirms Buy Rating for G1 Therapeutics (NASDAQ:GTHX)
marketbeat.com - January 24 at 8:36 AM
seekingalpha.com logoG1 Therapeutics: New Financials And Big Data Readout Alert
seekingalpha.com - January 9 at 10:14 AM
finance.yahoo.com logoG1 Therapeutics Provides Corporate Update at the 42nd Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 8 at 7:57 AM
marketbeat.com logoShort Interest in G1 Therapeutics, Inc. (NASDAQ:GTHX) Expands By 9.1%
marketbeat.com - January 3 at 9:19 PM
finance.yahoo.com logoInsider Sell: President and CEO Bailey John E. (Jack) Jr. Sells 32,983 Shares of G1 Therapeutics Inc
finance.yahoo.com - January 3 at 5:39 PM
finance.yahoo.com logoG1 Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 3 at 12:38 PM
Get G1 Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for GTHX and its competitors with MarketBeat's FREE daily newsletter.

These AI trades triggered this morning (545% return) (Ad)

If you think a market crash is possible in 2024, I don't know why you're not using this yet.

Click Here To Get Your Free Copy

GTHX Media Mentions By Week

GTHX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

GTHX
News Sentiment

1.32

0.65

Average
Medical
News Sentiment

GTHX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

GTHX Articles
This Week

6

2

GTHX Articles
Average Week

Get G1 Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for GTHX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:GTHX) was last updated on 4/14/2024 by MarketBeat.com Staff

From Our Partners